Nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in neoadjuvant chemotherapy for resectable breast cancer: Phase II trial. (March 2017) - Kin, T.; Fujihara, M.; Yoshimura, Y.; Kajiwara, Y.; Ito, M.; Ohtani, S.; Taniguchi, K.; Morito, T.; Takada, S.; Ichimura, K.